ArchiMed SAS
PE/Buy-Out · Lyon (France)
Sign up free to access full profile and submit your pitch.
About
ArchiMed SAS is a private equity and venture capital firm specializing investing in small and middle market, growth buyouts, acquisitions, small-cap and mid-cap companies. The firm seeks to invest in healthcare industries with focus on biopharmaceutical products & services, life science tools, biologic services, medical devices & technologies, diagnostics, healthcare IT and consumer health. In Biopharma firm prefers to invest in small and large molecules, APIs, generic, primary and specialty pharma, pharma delivery, veterinary, outsourcing services such as bioanalytical, drug discovery or formulation services, Consumer Health, In Vitro Diagnostics, CRO, CDMO, CLO or specialized consulting, in Healthcare IT firm prefers to invest in clinical or non-clinical solutions for care providers, care payer solutions, biopharma-related software, outsourcing services. In care provider firm prefers to invest in homecare, specialized care delivery, outsourcing services, in Medtech firm provider, the firm prefers to invest in implants, equipment, consumables, services, outsourcing in field such as cardiovascular, dental, drug delivery, infection control, neuro, ophtalmo, orthopaedics, general surgery, wound care, veterinary, in public safety firm prefers to invest in biocontrol, food safety, environmental and healthcare-related TIC, health at work, in Diagnostics it prefers to invest in including In Vitro (IVD) and Imaging, in Life Sciences the firm prefers to invest in including tools, equipment, consumables and services, whether for bioprocessing, research, in consumer health it prefers to invest in cosmetics, health supplements, aesthetics, wellness, selfcare and physio. It prefers to invest in Europe, France, Switzerland, North America, APAC and LATAM region. It prefers to invest between €5 million ($5.36 million) and €1,000 million ($1,100 million) in the companies with sales value between $6.22 million and $124.33 million. It prefers to take majority and minority stake in the companies. ArchiMed SAS was founded in 2014 and is based in Lyon, France with additional offices in Paris, France; New York, New York; Singapore, Singapore and Tokyo, Japan.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
.png)
